OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NTR59

Nutrien Ltd

Agricultural ChemicalsVerified

Nutrien operates with a debt-to-equity ratio of 0.55, indicating a moderate reliance on debt financing, and a current ratio of 1.15, suggesting limited short-term liquidity cushion. The company reported negative operating cash flow of -$487 million and free cash flow of $96 million, reflecting uneven cash generation despite capital expenditures of -$373 million. These figures suggest a need for careful liquidity management, particularly given the company's long-term debt of $13.64 billion. Profitability metrics show a return on equity of 0.63% and a return on assets of 0.29%, both below the industry median for Agricultural Chemicals, which typically sees higher returns due to pricing power and scale. Gross profit of $1.54 billion and operating income of $419 million indicate margin compression, likely driven by input cost inflation and competitive pricing pressures in the global fertilizer market. Nutrien's revenue is concentrated in its core agricultural chemicals business, with no material diversification into other product lines or services. Geographically, the company is heavily exposed to North America, where it operates the majority of its production facilities and serves a large domestic customer base. This concentration increases vulnerability to regional economic downturns and regulatory shifts. The company's growth trajectory is mixed. While revenue for the latest period was $5.39 billion, the outlook for the current fiscal year shows a modest increase, with analysts projecting a mean price target of $78.27 per share. However, the median price target of $79.00 and the high of $100.00 suggest a range of expectations, with some analysts optimistic about long-term fundamentals in the agricultural inputs sector. Risk factors include medium liquidity risk due to negative net cash and a high debt load, as well as potential dilution from future capital raises, though the risk of dilution is currently assessed as low. The company's exposure to volatile commodity prices and geopolitical tensions in key export markets, such as China and India, adds to its operational risk profile. Recent events include a 10-K filing that highlighted ongoing supply chain disruptions and inflationary pressures, as well as a Q4 earnings call where management reiterated its focus on cost control and asset optimization. No major regulatory or legal developments were disclosed in the latest filings, but the company remains subject to environmental and safety regulations in its primary markets.

30-day price · NTR-4.62 (-6.3%)
Low$67.80High$77.74Close$68.73As of27 May, 00:00 UTC
Profile
CompanyNutrien Ltd
TickerNTR.TO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Nutrien Ltd is a Canadian company that produces and distributes agricultural fertilizers and crop inputs, primarily generating revenue through the sale of nitrogen, phosphate, and potash products.

Classification. Nutrien is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry, with a classification confidence of 0.92.

Nutrien operates with a debt-to-equity ratio of 0.55, indicating a moderate reliance on debt financing, and a current ratio of 1.15, suggesting limited short-term liquidity cushion. The company reported negative operating cash flow of -$487 million and free cash flow of $96 million, reflecting uneven cash generation despite capital expenditures of -$373 million. These figures suggest a need for careful liquidity management, particularly given the company's long-term debt of $13.64 billion. Profitability metrics show a return on equity of 0.63% and a return on assets of 0.29%, both below the industry median for Agricultural Chemicals, which typically sees higher returns due to pricing power and scale. Gross profit of $1.54 billion and operating income of $419 million indicate margin compression, likely driven by input cost inflation and competitive pricing pressures in the global fertilizer market. Nutrien's revenue is concentrated in its core agricultural chemicals business, with no material diversification into other product lines or services. Geographically, the company is heavily exposed to North America, where it operates the majority of its production facilities and serves a large domestic customer base. This concentration increases vulnerability to regional economic downturns and regulatory shifts. The company's growth trajectory is mixed. While revenue for the latest period was $5.39 billion, the outlook for the current fiscal year shows a modest increase, with analysts projecting a mean price target of $78.27 per share. However, the median price target of $79.00 and the high of $100.00 suggest a range of expectations, with some analysts optimistic about long-term fundamentals in the agricultural inputs sector. Risk factors include medium liquidity risk due to negative net cash and a high debt load, as well as potential dilution from future capital raises, though the risk of dilution is currently assessed as low. The company's exposure to volatile commodity prices and geopolitical tensions in key export markets, such as China and India, adds to its operational risk profile. Recent events include a 10-K filing that highlighted ongoing supply chain disruptions and inflationary pressures, as well as a Q4 earnings call where management reiterated its focus on cost control and asset optimization. No major regulatory or legal developments were disclosed in the latest filings, but the company remains subject to environmental and safety regulations in its primary markets.
Key takeaways
  • Nutrien's liquidity position is moderate, with a current ratio of 1.15 and negative operating cash flow.
  • Profitability metrics are below industry medians, indicating margin pressure and operational inefficiencies.
  • Revenue is heavily concentrated in the agricultural chemicals segment and North American markets.
  • Analysts project a mixed outlook, with a mean price target of $78.27 and a wide range of expectations.
  • The company faces medium liquidity risk and potential exposure to geopolitical and regulatory shifts.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$5.39B
Gross profit$1.54B
Operating income$419.0M
Net income$158.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$487.0M
CapEx-$373.0M
Free cash flow$96.0M
Total assets$53.58B
Total liabilities$28.62B
Total equity$24.95B
Cash & equivalents
Long-term debt$13.64B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$27.71B$4.64B$3.15B$2.30B
FY-3$37.88B$10.81B$7.66B$6.25B
FY-2$29.06B$2.75B$1.26B-$276.0M
FY-1$25.97B$1.86B$674.0M-$175.0M
FY0$26.89B$3.74B$2.27B$1.60B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$49.95B$23.65B
FY-3$54.59B$25.82B
FY-2$52.75B$25.16B
FY-1$51.84B$24.41B
FY0$52.30B$25.32B
PeriodOCFCapExFCFSBC
FY-4$3.89B-$1.78B$2.30B
FY-3$8.11B-$2.44B$6.25B
FY-2$5.07B-$2.67B-$276.0M
FY-1$3.54B-$2.15B-$175.0M
FY0$4.01B-$2.00B$1.60B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$5.39B$419.0M$158.0M$96.0M
FQ-6$10.16B$844.0M$385.0M$165.0M
FQ-5$5.35B$196.0M$18.0M-$174.0M
FQ-4$5.08B$397.0M$113.0M-$262.0M
FQ-3$5.10B$226.0M$11.0M$25.0M
FQ-2$10.44B$1.78B$1.22B$1.15B
FQ-1$6.01B$807.0M$464.0M$291.0M
FQ0$5.34B$921.0M$571.0M$133.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$53.58B$24.95B
FQ-6$52.99B$25.13B
FQ-5$51.91B$24.97B
FQ-4$51.84B$24.41B
FQ-3$53.07B$24.04B
FQ-2$53.26B$25.09B
FQ-1$51.83B$25.12B
FQ0$52.30B$25.32B
PeriodOCFCapExFCFSBC
FQ-7-$487.0M-$373.0M$96.0M
FQ-6$1.32B-$920.0M$165.0M
FQ-5$412.0M-$1.45B-$174.0M
FQ-4$3.54B-$2.15B-$262.0M
FQ-3-$1.08B-$300.0M$25.0M
FQ-2$1.46B-$724.0M$1.15B
FQ-1$1.03B-$1.25B$291.0M
FQ0$4.01B-$2.00B$133.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$24.95B
Net cash-$13.64B
Current ratio1.1
Debt/Equity0.6
ROA0.3%
ROE0.6%
Cash conversion-3.1%
CapEx/Revenue-6.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricNTRActivity
Op margin7.8%5.5% medp25 -0.0% · p75 10.8%above median
Net margin2.9%4.1% medp25 0.1% · p75 8.8%below median
Gross margin28.5%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.9%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity55.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target78.27 USD
Median price target79.00 USD
High price target100.00 USD
Low price target61.00 USD
Mean recommendation2.17 (1=strong buy, 5=strong sell)
Strong-buy count5.00
Buy count11.00
Hold count5.00
Sell count2.00
Strong-sell count0.00
Mean EPS estimate5.99 USD
Last actual EPS4.56 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 06:59 UTC#12e14c46
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 19:20 UTCJob: 438403fe